Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence

PHASE2CompletedINTERVENTIONAL
Enrollment

491

Participants

Timeline

Start Date

August 21, 2017

Primary Completion Date

September 21, 2018

Study Completion Date

September 21, 2018

Conditions
Stress Urinary Incontinence
Interventions
DRUG

GTx 024

Study drug is an opaque, white to off-white, size 5, oval Softgel capsule containing the active ingredient GTx-024.

DRUG

Placebo

Placebo study drug is identical in appearance to the GTx-024 study drug and contains polyethylene glycol 400 but not GTx-024.

Trial Locations (62)

10016

Manhattan Medical Research Practice PLLC, New York

11530

Accumed Research Associates, Garden City

12601

Premier Medical Group, Poughkeepsie

14224

Circuit Clinical, West Seneca

18103

Institute for Female Pelvic Medicine, Allentown

19004

Urologic Consultants of Southeastern PA LLP, Bala-Cynwyd

19104

University of Pennsylvania Health System, Philadelphia

20036

James A Simon MD PC, Washington D.C.

21076

Chesapeake Urology Associates PA, Hanover

23462

Urology of Virginia, Virginia Beach

27403

Alliance Urology Specialist PA, Greensboro

28207

American Health Research Inc, Charlotte

28562

Eastern Carolina Women's, New Bern

29464

Coastal Carolina Research Center, Mt. Pleasant

29572

Carolina Urologic Research, Myrtle Beach

30328

Mount Vernon Clinical Research LLC, Sandy Springs

32720

Midland Florida Clinical Research Center LLC, DeLand

33060

Clinical Research Center of Florida, Pompano Beach

33145

Lone Star Research Center, Miami

33180

South Florida Medical Research, Aventura

33186

Medical Research of Florida, Miami

33319

Precision Clinical Research, Lauderdale Lakes

33761

Tampa Bay Medical Research Inc, Clearwater

35209

Urology Center of Alabama, Homewood

36608

Coastal Clinical Research Inc, Mobile

38305

The Jackson Clinic, Jackson

43213

Aventiv Research, Columbus

44195

Cleveland Clinic, Cleveland

45212

The Urology Group, Cincinnati

47130

First Urology PSC, Jeffersonville

48073

William Beaumont Hospital Urology Research, Royal Oak

49009

Beyer Research, Kalamazoo

50266

Iowa Clinic, West Des Moines

60453

Women's Health Institution of Illinois, Oak Lawn

68510

Women's Clinic of Lincoln, Lincoln

70115

DelRicht Clinical Research, LLC, New Orleans

71106

Regional Urology, Shreveport

75231

Urology Clinics of North Texas, Dallas

78229

Clinical Trials of Texas Incorporated, San Antonio

Urology San Antonio Research PA, San Antonio

78758

Elligo - Austin Area OBGYN, Austin

80113

Urology Associates Research, Englewood

80220

Genitourinary Surgical Consultants, Denver

83221

Clinical Research Prime, Idaho Falls

83642

Idaho Urologic Institue, Meridian

84041

Synexus Clinical Research Advantage, Inc. - Wasatch Peak Family Practice, Layton

85054

Mayo Clinic Arizona, Phoenix

85741

Urological Associates of Southern Arizona, Tucson

89144

Sheldon J Freedman MD Ltd, Las Vegas

90603

American Institute of Research, Whittier

92111

Women's Healthcare Research Corporation, San Diego

98043

Urology Northwest PS, Mountlake Terrace

98105

Seattle Womens: Health, Research, Gynocology, Seattle

99503

Alaska Clinical Research Center, Anchorage

06032

Women's Health Specialty Care, Farmington

06320

Coastal Connecticut Research, LLC, New London

06859

Bladder Control Center of Connecticut, Norwalk

02131

Boston Clinical Trials, Boston

02472

Bay State clinical Trials, Watertown

08837

Premier Urology Group, LL, Edison

08648

Lawrence Obs Gyn clinical Research, Lawrenceville

08054

Delaware Valley Urology, Mount Laurel

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GTx

INDUSTRY

NCT03241342 - Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence | Biotech Hunter | Biotech Hunter